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1. Introduction  
Imaging tools that aid in identifying the precise location of diseased cells within a patient’s 
tissues, and that measure the physiological status of these cells, have clear impact for 
medical scientists in a wide range of specialties ranging from clinical oncology to cardiology 
to neurology. Furthermore, laboratory scientists can utilize imaging methods to gain insight 
into the subcellular localization and kinetics of key branches for major biosynthetic 
pathways. Our predominant focus for discussion in this chapter is imaging of living cellular 
systems, and we also discuss how dynamics of key cellular pathways can be revealed from 
observations in fixed cells. We discuss some of the recent advances that continue to lead 
scientists toward imaging metabolic pathways for understanding and diagnosing human 
disease. The goal of this chapter is to provide the novice researcher with an overview of a 
variety of approaches for imaging cellular metabolism both for medical and research 
purposes. 
Understanding the metabolic differences between normal cells and cancer cells is a major 
objective of biomedical research. Cancer cells exhibit increased metabolic rates for pathways 
needed to support uncontrolled cellular proliferation, and this has been exploited for 
treatment of tumors as well as for diagnostic purposes (Locasale et al., 2009). The problem 
for understanding and treating cancer is to learn not only what makes each specific type of 
cancer unique, but also to learn the commonly aberrant pathways in cancers such as higher 
glucose metabolism or altered membrane biosynthesis pathways that can be exploited as 
targets for developing diagnostic tools and anticancer therapies. There is continued hope for 
novel therapies not only in the well-documented oncogene/tumor suppressor-related 
cellular signaling pathways, but also in areas of renewed interest, such as unique regulation 
of stress response pathways by cancer cells (reviewed in Luo et al., 2009). Regardless of the 
pathway targeted, cancer therapy would ideally leave normal cells unaffected while 
specifically interfering with altered metabolic pathways of cancer cells.  
2. Exploiting aberrant metabolism to image cancer cells 
Increased glucose metabolism in cancer cells, initially observed by Warburg over 90 years 
ago, has fueled the development of labeled metabolites to differentially label cancer cells 
from surrounding normal tissues (Warburg, O., 1956). To detect the labeled malignant 
tissue, the use of minimally invasive in vivo imaging techniques has increased rapidly over 
the last two decades. Here we briefly describe various types of metabolites and the imaging 
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methods used to observe cancer cells in vivo. Of particular interest is the use of imaging 
techniques in conjunction with labeled metabolic markers to determine location, size and 
response to drug treatment of cancerous tissue in vivo. The current non-invasive imaging 
techniques include but are not limited to positron emission tomography (PET), magnetic 
resonance spectroscopy (MRS), magnetic resonance imaging (MRI), single-photon emission 
computed tomography (SPECT) and computed tomography (CT). These techniques have 
been extensively reviewed elsewhere and the reader is encouraged to refer to those recent 
articles (Plathow & Weber, 2008; Condeelis & Weissleder, 2010).  
2.1 In vivo imaging probes 
According to the Molecular Imaging and Contrast Database (MICAD), there are currently 
1107 imaging probes and contrasting agents currently used for in vivo studies (Chopra et al., 
2011). The most commonly used metabolic marker is the synthetic glucose analog, 2-deoxy-
2-(18F)fluoro-D-glucose (FDG) (Ido et al., 1978). FDG has wide clinical use because malignant 
cells display high glucose metabolic rates as compared to normal tissue (Warburg, 1956, 
Sokoloff et al. 1977). In the cell, FDG becomes phosphorylated by hexokinase, it can not be 
further metabolized, and it is in essence trapped within the cell. FDG uptake is therefore 
indicative of the rates of both glucose uptake and glucose phosphorylation. FDG uptake is 
monitored using PET and this method of probe detection has become the choice of clinicians 
for identifying tumors in vivo and has been used to successfully detect head and neck, 
prostate, breast, lung and liver cancer (Ben-Haim & Ell, 2009). Additional metabolic 
processes have been targeted for clinical use, and PET metabolic markers have been 
developed that detect apoptosis, angiogenesis, hypoxia, cell proliferation and amino acid 
metabolism. Metabolic markers currently being used include [11C]Methionine, L-[3-18F]--
methyltyrosine [18F]FMT, [11C]Thymidine, 18F-3'-fluoro-3'-deoxy-thymidine [18F]FLT, 
[11C]Choline [18F]Choline, [11C]Acetate, 68Ga-NOTA-RGD [18F]Galacto-RGD, 18F-
fluoromisonidazole [18F]FMISO, [18F]FAZA, 64Cu-ATSM, 99mTc-Annexin-V and 
[124I]Annexin-V (reviewed in Lee, 2010). Here we highlight PET markers that are associated 
with cell proliferation, amino acid metabolism and lipid metabolism. 
Collectively [11C]Methionine, [18F]FMT, [11C]Thymidine and [18F]FLT are used as indicators 
of cell proliferation. These compounds can further be classified into amino acid and nucleic 
acid analogs. The radiolabeled amino acid [11C]methionine, is easily taken up by tumor cells 
due to their increased protein synthesis, and has been very useful for identifying 
malignancies in the central nervous system (Comar et al., 1976, reviewed in Nanni et al., 
2010). Furthermore, the amount of [11C]methionine present in malignant tissue can be used 
to determine tumor grade (reviewed in Nanni et al., 2010). For example,  [11C] methionine, 
was recently used to grade the aggressiveness of glioblastoma in patients with grade IV 
gliomas (Kawai et al., 2011). Additionally, [11C]Methionine/ PET is a promising tool for 
determining active tumor regions providing valuable information for chemotherapy (Tsien 
et al., 2011). Deng et al. (2011) recently synthesized S-11C-methyl-L-cysteine as a PET tracer 
and suggest that it shows improved distinction between malignant tissue and inflammatory 
response as compared with [11C]Methionine.  
[18F]FMT as a metabolic indicator is useful for detecting tumors and monitoring response to 
therapy. Biochemically, FMT is a tyrosine analog that is not incorporated into nascent 
proteins; however, it does reflect amino acid uptake that is increased in cancer cells 
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(Ishiwata et al., 2004). In patients with non-small cell lung carcinoma, FMT uptake in 
primary adenocarcinoma was suggested to be an indicator of poor prognosis (Kaira et al.,  
2009). FMT has also been useful in identifying bone lesions (Ishiwata, et al., 2004). The D 
isomer of FMT was used to monitor squamous cell carcinoma in a mouse model system. 
Irradiated mice showed a decrease in uptake D-FMT after radiation in contrast to FDG and 
11C Met (Murayama et al., 2009). These results suggest that D-FMT may be a good indicator 
of early tumor response to treatment. The nucleotide analogs [11C] thymidine and [18F]FLT 
have also been used to detect malignancies. FLT is a thymidine analog that can be 
phosphorylated by thymidine kinase 1 which is elevated in proliferating cells (Rasey, et al., 
2002). Phosphorylation traps FLT, resulting in its accumulation in cells. While FLT 
undergoes phosphorylation it is not clear if it is incorporated in DNA. Like FMT, FLT has 
been most useful in monitoring tumor response to therapy (reviewed in Barwick et al., 
2009). In fact, FLT was similar to FMT in its ability to monitor early tumor response to 
radiation (Murayama, et al., 2009). 
Both [11C]Choline and [18F]Choline, are indicators of phospholipid metabolism in cells. 
Choline is transported into cells where it is metabolized to phosphocholine by choline 
kinase, an enzyme that is frequently upregulated in tumor cells (Ramirez de Molina, et al. 
2002 a,b). Phosphocholine is negatively charged and remains trapped within the cells. 
Labeled choline has been used extensively in prostate cancer studies. For example, an 
increase of 11C choline in prostatic malignancies has been recently been shown to be an 
indicator of aggressiveness in prostate cancer patients (Piert et al., 2009). Several recent 
reviews discuss imaging in prostate cancer and the reader is directed to these reviews for 
further reading (Edmonds et al., 2009; Jadvar, 2009; Zaheer et al., 2009). Labeled choline, 
including 18F-fluoroethylcholine in animal models, has also been used to detect 
hepatocellular carcinoma and brain tumors (Talbot et al., 2006; Kubota et al., 2006; 
Kolthammer et al., 2011).  
Acetate is taken up by cells, converted to acetyl CoA and ultimately incorporated into the 
cell membrane (Howard & Howard, 1975). [11C]Acetate has recently been used to detect 
increased glial tumor metabolism (Liu et al., 2006; Tsuchida et al., 2008). 2-18F-fluoroacetate 
has been successful in detecting glioblastoma in a mouse model system (Marik et al., 2009). 
Like labeled choline, labeled acetate is also a useful tracer for prostate cancer. A review has 
recently been published by Jadvar (2011) comparing the use of labeled acetate versus FDG 
or labeled choline and discussing the utility of these imaging probes in prostate cancer 
detection. 
2.2 Imaging of molecular complexes in living cells 
Our knowledge about the function of molecular complexes and their subcellular localization 
has rapidly expanded with the development of a wide array of encoded fluorescent 
probes that have enabled direct observation of metabolic pathways in living cells (reviewed 
in Zhang et al., 2002). Several of these probes utilize fluorescence resonance energy transfer 
(FRET) to detect interaction between molecules or to assess cellular levels of metabolites and 
monitor their compartmentalization. Among such FRET probes that sense metabolites, 
“cameleon” measures intracellular calcium (Miyawaki et al., 1997), and other probes have 
been designed to non-destructively sense phosphorylation by specific kinases such as 
protein tyrosine kinases (Ting et al., 2001) or protein kinase A (Zhang et al., 2001). 
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Fluorescent nanosensors have also been developed for concentration-dependent sensing of 
maltose in yeast (Fehr et al., 2002), as well as for detecting glucose uptake and subcellular 
compartmentalization (Fehr et al., 2003; Fehr et al., 2005) or ribose uptake (Lager et al., 2003) 
in mammalian cells. Furthermore, bimolecular fluorescence complementation (BiFC) can 
detect interaction between protein partners in living cells. Individual proteins are fused with 
non-fluorescent fragments of green fluorescent protein (GFP; or one of its variants). If the 
two fusion proteins interact, this brings the GFP fragments in close enough proximity to 
reconstitute fluorescence, and imaging reveals subcellular localization of the complex (Hu et 
al., 2002). Multicolor BiFC allows detection of multiple complexes simultaneously in living 
cells, and it can be used to measure the efficiency of complex formation between a protein of 
interest and each of its known partners (Hu & Kerppola, 2003). One example for how BiFC 
can be used to monitor cell physiological readout for cancer pathways in single cells was 
recently demonstrated by visualizing activation of caspase-2, the initiator caspase for 
mitochondrial apoptosis pathway (Bouchier-Hayes et al., 2009). This is interesting in light of 
the evidence that caspase-2 is a tumor suppressor. Caspase -/- mouse embryonic fibroblasts 
(MEFs) resisted apoptosis, and they showed increased proliferation as well as tumor 
formation most likely compounded by lost function of p53 (Ho et al., 2009).  
3. Nuclear organization and gene expression 
3.1 Nuclear organelles 
Organization of nuclear compartments can reflect metabolic status in mammalian cells. This 
is exemplified by numerous accounts of altered nuclear structure, nuclear organelles and 
nuclear biochemistry observed in a wide range of diseases. Tying altered gene expression to 
changes in nuclear organization is an area of intense current research (reviewed in 
Rajapaske and Groudine, 2011). Among the best examples of such observable alteration is 
seen in the perinucleolar compartment (PNC), a nuclear organelle found adjacent to the 
nucleolus that contains RNA binding proteins and is enriched with transcripts synthesized 
by RNA polymerase III (Huang et al., 1998). Metabolism of RNA polymerase III transcripts 
is suggested as a primary factor regulating PNC size (Wang et al., 2003). Variation in PNC 
size is medically relevant because the size of the PNC has been directly correlated with 
disease staging. Analysis of clinically staged breast cancer tissue samples showed that 
presence of PNCs increases with disease progression, such that metastatic tumors have the 
largest and most abundant PNCs (Kamath et al., 2005). Because PNC prevalence correlated 
with metastatic potential and malignancy in other solid tumors (Norton et al., 2008), PNC 
status can therefore be used as a simple and relatively low-cost prognostic marker for tumor 
progression. Further study is needed to determine if the PNC changes occur in other 
cancers, or if the changes are a result or a cause of cellular transformation. Regardless, 
defining the primary functions of the PNC and understanding the biochemical pathways 
housed in this nuclear organelle could lead to developing very specific tools for knocking 
out breast tumors and other types of tumors. Along these lines, an automated high-
throughput imaging screen performed in living cells expressing fluorescently tagged PNC 
component polypyrimidine tract binding protein (PTB-GFP) identified compounds that 
disassemble the PNC (Norton et al., 2009). This work shows promise not only for cancer 
drug development, but also for the general assessment and screening of compounds that 
effect nuclear structural changes, as well as for scientists to determine where compounds 
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interfere with cellular biochemistry in order to better understand the metabolic pathways 
that regulate metastasis.  
Despite decades of intense research, new players involved in protein coding gene expression 
are still being identified and characterized. Many of the factors localize to specific nuclear 
organelles such as Cajal bodies and nuclear speckles (also called SC35 domains or 
interchromatin granule clusters; reviewed in Spector and Lamond, 2010) Nuclear speckles 
are storage sites for pre-mRNA processing factors from which factors are exchanged with 
the nucleoplasm and recruited to nascent transcripts for co-transcriptional pre-mRNA 
processing (reviewed in Spector & Lamond, 2010). The organization of nuclear speckles 
reflects as well as impacts the global status of pre-mRNA synthesis and the efficiency of pre-
mRNA processing. Inhibition of RNA polymerase II by alpha-amanitin supports the 
recruitment model, as this treatment causes RNA processing factors to remain in enlarged 
rounded nuclear speckles speckle rounding (Lamond & Spector, 2003). Disassembly of 
nuclear speckles distributes components throughout the nucleoplasm and alters pre-mRNA 
processing (Sacco-Bubulya & Spector, 2002). Purification of nuclear organelles has identified 
many of the nuclear proteins whose components are used for synthesis and processing of 
RNA (Mintz et al., 1999; Saitoh et al., 2004; Andersen et al., 2004) and is beginning to reveal 
functions for RNAs (Prasanth et al., 2005; Tripathi et al., 2010). Polyadenylated RNA was 
previously shown to be enriched in nuclear speckles by fluorescence in situ hybridization 
methods (Visa et al., 1993; Huang et al., 1994). As these new players are identified, synthetic 
gene reporter systems will be incredibly useful tools for determining the kinetics of their 
assembly at transcription sites, as well as to pin down their specific functions in gene 
expression. 
Visualizing biosynthetic pathways in the nucleus has relied on a variety of experimental 
approaches. Labeling cellular structures or contents (e.g. lipids, mitochondria, DNA) non-
immunologically with fluorescent molecules, or by using immunocytochemical approaches, 
has been described extensively elsewhere (Spector & Goldman, 2006). Incorporation of 
nucleotide analogs into nascent strands is a common way to label nucleic acids during their 
synthesis, and can be used to visualize entire chromosomes, individual DNA replication 
foci, or transcription factories. Nucleotide analogs can be radioactive, enzymatic, fluorescent 
or in some other way tagged for detection. Radioactive nucleotide incorporation relies on 
detection by autoradiography which has the disadvantage of requiring long exposure times 
of several months, offers low resolution, and is not typically the preferred labeling method. 
Recent technical advances using nucleotide incorporation approaches or various molecular 
tagging methods, as well as advances in super-resolution imaging systems (Huang et al., 
2009), are certain to continue rapidly expanding our knowledge about localization and 
kinetics of nuclear pathways.  
3.2 Transcription and RNA processing 
BromoUTP incorporation is a widespread tool for to labeling transcription sites in situ. Cells 
are gently permeabilized to allow uptake of nucleotide analog, followed by incubation in a 
transcription buffer cocktail that promotes elongation of nascent transcripts (Haukenes et 
al., 1997). A short pulse of labeling in mammalian cells (~5-8 minutes at 37 degrees Celsius 
for HeLa cells) is sufficient to globally label nascent RNA, which can be subsequently 
detected in transcription foci throughout the nucleus corresponding to RNAs synthesized 
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predominantly by RNA polymerases II and III (Sharma et al., 2010; Sacco-Bubulya and 
Spector, 2002) or specifically in nucleoli corresponding to ribosomal RNAs synthesized by 
RNA polymerase I (Dundr et al., 2002). Fluorouridine is also useful for labeling transcription 
sites in situ (readers should note that this is halogenated, not fluorescent), and has the 
advantage that it directly enters the cells without the need for detergent permeabilization 
(Boisvert et al., 2000). In addition, permeabilizing cells using different detergents and 
various permeabilization times can affect labeling efficiency, for example, in nucleolar 
transcription foci versus transcription foci in the nucleoplasm, and nucleotide analogs 
appear to be incorporated with different degrees of efficiency in distinct nuclear 
compartments in mammalian cells (P. Bubulya, unpublished observations). RNAs 
synthesized by distinct RNA polymerases I, II or III have been shown in dedicated nuclear 
transcription “factories” by sophisticated twists on BrUTP incorporation methods (Pombo et 
al., 1999). Regardless, in all these studies the cells are not alive; following pulse labeling, 
removal of excess nucleotide, and fixation of the cells, nucleotide incorporation is detected 
by subsequent labeling of the halogenated nucleotide. Studies in living cells have revealed 
information regarding the kinetics of transcription and processing machinery assembly and 
transcript elongation rates for RNA polymerases I and II (Dundr et al., 2002; Kimura et al., 
2002) as well as the cell cycle regulated assembly of the nuclear organelles that house these 
machineries. 
The synthesis and processing of ribosomal RNAs for ribosome production is the most robust 
gene expression pathway in mammalian cells. Although products of all RNA polymerases 
are required for final assembly of ribosomes, ribosome biogenesis occurs in nucleoli 
(reviewed in Leary & Huang, 2001, Hernandez-Verdun et al., 2002). Activation of the rRNA 
genes evades global inhibition of transcription on condensed chromosomes during mitosis. 
Imaging methods have demonstrated the involvement of pre-rRNAs in the onset of 
nucleolar organization at daughter cell chromatin and that different chromatin regions 
containing rRNA genes come together during nucleolar maturation (Hernandez-Verdun et 
al., 2002). Ribosomal components are delivered to newly forming nucleolar bodies as they 
are needed for pre-rRNA processing, and individual components show rapid exchange in 
and out of these bodies during assembly (Dundr et al., 2000). During interphase, individual 
components of RNA polymerase I enter nucleoli independent of others, and different 
incorporation efficiency and nucleolar residence time for independent components suggests 
sequential assembly of complexes with each round of transcription (Dundr et al., 2002).  
Reporter gene constructs that have been engineered and stably integrated into cellular 
genomes to visualize RNA polymerase II transcription in living cells made it possible to 
study the position and activity of transcription sites in real time, in the context of chromatin 
structure and global nuclear organization. Tandem arrays of DNA containing repeated 
binding sites for fluorescently-tagged DNA binding proteins can be stably integrated into 
chromatin where they become assembled into higher order chromatin structure. These 
arrays have been used to visualize chromatin dynamics, and they have been coupled to 
reporter genes downstream to visualize the kinetics of chromatin unfolding and transcript 
synthesis in living cells (reviewed in McNally, 2009 and in Rafalska-Metcalf & Janicki, 2007).  
In one system, integrated tandem arrays of mouse mammary tumor virus driving a ras 
reporter (called MMTV-LTR-ras-BPV) created a specific locus containing 800-1200 binding 
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sites for gluococorticoid receptor (GR). Following controlled expression of a GFP-tagged-GR 
(GFP-GR) and hormone addition, GR nuclear translocation as well as GR-GFP recruitment 
to the locus were observed in living cells (McNally et al., 2000). Photobleaching techniques 
determined that GFP-GR undergoes its rapid exchange on locus chromatin (McNally et al., 
2000). Reporter transcripts were detected by RNA fluorescence in situ hybridization (RNA-
FISH) in the vicinity of GR-GFP accumulation on the reporter locus. Since GR-GFP reflected 
the underlying DNA binding sites on chromatin, the extent of locus chromatin 
decondensation could in turn be observed and correlated with the amount of transcription 
at that site (Muller et al., 2001). 
Other systems have been developed to allow visualization of chromatin independent of 
transcription activity, such that both the transcriptional inactive and transcriptionally active 
chromatin can be observed, and the transitions between these two states can be studied. One 
such system consists of a tandem array of synthetic reporter sequences in baby hamster 
kidney (BHK) cells containing lac operator repeats proximal to an inducible reporter gene 
encoding cyan fluorescent protein that is targeted to peroxisomes via a serine-lysine-leucine 
tag (SKL; Tsukamoto et al., 2000). Expression of fluorescently-tagged lac repressor protein in 
these cells labels the locus chromatin, and inducing transcription allows live observation of 
the transition from the inactive to active state, revealing continued chromatin 
decondensation at the locus over the time course of imaging (Tsukamoto et al., 2000). While 
reporter transcripts could be detected in that system by RNA-FISH, this method does not 
allow real time imaging of transcripts. The same basic reporter system was then further 
developed such that transcripts would contain MS2 bacteriophage viral replicase 
translational operator sequences (MS2 stem loops). These sequences are recognized by the 
MS2 coat protein that can be fluorescently tagged and expressed in the reporter cells for 
imaging transcription in real time (Janicki et al., 2004). This latter system, referred to as 
U2OS 2-6-3, enables visualization of DNA, RNA and protein product for a single reporter 
locus in living cells (Janicki et al., 2004). For that reason, it is a very powerful tool for 
understanding all the steps of RNA polymerase II-mediated gene expression in any phase of 
the cell cycle. For example, the transition from condensed to decondensed chromatin, the 
switch from heterochromatic to euchromatic modifications, the exchange of histones 
H3/H3.3, the recruitment of transcription factors, the kinetics of reporter transcript 
production, and the recruitment of pre-mRNA processing machinery were all observed in 
living cells (Janicki et al., 2004). A further advantage of these live cell reporter systems for 
transcription is that the lac repressor can be fused both with a fluorescent protein AND a 
second protein/domain that sequesters it to a particular subnuclear compartment. For 
example, fusing lac repressor to the fluorescent protein mCherry and to lamin B1, and 
placing the expression of this triple fusion protein under the control of an inducible 
promoter, allowed for inducible tethering of a reporter locus to the nuclear periphery 
(Kumaran and Spector, 2008). Despite that the peripheral regions of the nucleus are 
generally thought of as heterochromatic and transcriptionally silent, this reporter locus 
retained its transcriptional activity upon relocation to the nuclear lamina. This tethering 
system opens many possibilities for gaining both spatiotemporal and kinetic information 
about gene expression events occurring on a gene locus during its nuclear repositioning, as 
well as a novel way to test how nuclear compartments in diseased cells might demonstrate 
misregulated gene expression pathways  (Kumaran and Spector, 2008). 
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Many continuing studies are using such systems to learn more about transcription 
regulation and how it relates to nuclear dynamics or RNA trafficking. The involvement of 
proteins and RNAs in pre-mRNA synthesis and processing, or on chromatin 
condensation/decondensation during gene regulation can be systematically evaluated 
either by RNAi-mediated knockdown or overexpression studies. For example, depletion of 
7SK RNA resulted in upregulation of transcription on a modified version of the U2OS 2-6-3 
gene reporter system (Prasanth et al., 2010). Furthermore, the transcripts themselves can be 
observed directly in living cells. Individual mRNP particles can be tracked to gain 
information about mRNP movement through the nucleoplasm by using the U2OS 2-6-3 cells 
(Shav-Tal et al., 2004). Photoactivation studies showed the single mRNPs freely diffused in 
all directions as they moved away from the transcription site. In addition, general inhibitors 
of cellular metabolism surprisingly caused a decreased mobility of mRNP particles, mostly 
likely explained by overall restructuring of nuclear organization under these conditions, that 
was restored when energy levels were reset to normal (Shav-Tal et al., 2004). At least one 
new system has been recently developed for examining the trafficking of mRNA (and 
visualizing its protein product) that is certain to shed light on the spatial and temporal 
kinetics of synthesis, export, and cytoplasmic transport of mRNA to its cellular location 
where it is ultimately translated into protein (Ben-Ari, et al., 2010). Our capability for RNA 
imaging is on the verge of complete transformation due to a newly developed tool for 
tagging and imaging RNAs in living cells (Paige et al., 2011). This new “RNA version” of 
green fluorescent protein, called Spinach, was successfully used to image the dynamics of 5S 
ribosomal RNA in living cells. Spinach as well as other RNA-tagging molecules in a range of 
excitation and emission spectra will undoubtedly open new avenues for discovery with 
potential applications in RNA-RNA and RNA-protein FRET (Paige et al., 2011). 
Pre-mRNA splicing regulation can be studied by using minigene reporters that typically 
contain only a small segment of genomic DNA from a given gene subcloned into a 
mammalian expression vector. A well-characterized beta-tropomyosin (BTM) minigene 
(Helfman et al., 1988; Huang & Spector, 1996) was stably integrated into HeLa cells (Sacco-
Bubulya and Spector, 2002; Sharma et al., 2011). The BTM minigene is useful for monitoring 
constitutive as well as alternative splicing of minigene transcripts. One advantage of 
expressing transcripts from reporter minigenes is that a comparison can be made between 
precursors versus spliced transcripts produced at the reporter locus that can be visualized 
by RNA-FISH (Sacco-Bubulya and Spector, 2002; Sharma et al., 2011). Altered splicing of the 
reporter transcript can be detected after various treatments, for example, RNAi-mediated 
depletion or overexpression of specific splicing factors. The extent of reporter transcript 
processing can be monitored in situ. Sharma et al. (2011) recently demonstrated that HeLa 
cells treated with siRNA duplexes targeting the splicing factor Son showed increased 
skipping of exon 6 in BTM transcripts both by quantitative PCR and by RNA-FISH. In 
addition, a genome-wide screen identified human transcription and splicing targets for Son 
that include chromatin modifiers and cell cycle regulators (Sharma et al., 2011).  
Many of the above mentioned reporter gene loci have been instrumental in studying the 
onset of pre-mRNA synthesis and processing in post-mitotic nuclei. Somewhat similar to 
what was observed during nucleolar reassembly following mitosis, sequential nuclear entry 
of pre-mRNA synthesis and processing factors also occurs in an ordered sequence according 
to the timing for when factors are needed (Prasanth et al., 2003). Interestingly, transcription 
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factors and RNA polymerase II are detected in daughter nuclei first, followed by RNA 
processing factors. Only after all components are available in the nucleus for coupled RNA 
synthesis and processing are the elongating RNA polymerase II and exon junctions in 
reporter mRNAs detected (Prasanth et al., 2003). Recently, live cell imaging demonstrated 
that specific factors regulate post-mitotic reinitiation of transcription (Zhao et al., 2011). 
Active transcription sites are remembered, or “bookmarked”, by histone post-translational 
modification, specifically by histone H4 lysine 5 acetylation. This mark persists on 
transcriptionally inactive mitotic chromatin. Bromodomain protein 4 (BRD4) recognizes this 
mark to increase kinetics of RNA polymerase II transcription on a reporter locus following 
mitosis as compared to interphase cells (Zhao et al., 2001). 
4. DNA replication 
5-Bromodeoxyuridine (BrdU) incorporation is a common way for observing DNA 
replication in situ, and it is useful for general labeling of nuclear replication foci. Typically a 
pulse of BrdU is administered to live synchronized cells, and localization of the BrdU is 
observed after preserving cells by fixation and immunofluorescence labeling with antibodies 
against BrdU to show progression of replication in different subnuclear regions over time 
(Nakamura et al., 1986). This approach proved to be substantially better than radioactive 
nucleotide incorporation for replication labeling due to limited spatial resolution of 
autoradiography. Perhaps continued development of more sensitive and faster methods to 
incorporate nucleotide analogs will open new avenues for DNA replication studies. One 
such approach employs 5-ethenyl-2’-deoxyuridine incorporation followed by detection 
using “click” chemistry. This approach is useful in that it can be done in live cells or tissues 
to label cells in S-phase and also for direct imaging and high-throughput applications, 
although the cytotoxicity of the reaction prevents long-term cell survival (Salic & Mitchison, 
2008). All these types of approaches have been used widely to label replicating DNA.  
The overall DNA replication pattern changes progressively through S-phase as different 
nuclear regions undergo DNA replication at different times, and this generally correlates 
with chromatin status such that euchromatin replicates earlier in S-phase than 
heterochromatin (O’Keefe et al., 1992). Labeling of replication foci has been done in a variety 
of cell types and with multiple different labeling methods that commonly rely on labeled 
nucleotide analog such as bromo- or biotinylated-dUTP, and allow for comparison of 
replication foci to other cellular structures (Nakayasu & Berezney, 1989). Similarly in live 
cell analysis by GFP-PCNA labeling, one can see that replication factories in live cells show 
limited subnuclear movement, and each individual replication site arises and recedes 
independently from others (Leonhardt, 2000). The global position of chromosome 
organization in interphase nuclei and through mitosis has been analyzed after tagged-dUTP 
incorporation as well as “chromosome painting” methods. Such approaches have shown 
that the gene density of chromosomes may position them differently in nuclear space. Gene-
dense chromosomes more frequently appear in the nuclear interior, while gene-poor 
chromosomes are found at the nuclear periphery (Bolzer et al., 2005; Spector 2003). In 
addition, the timing of replication for specific gene loci has been determined by coupling 
fluorescence in-situ hybridization methods with the nucleotide analog incorporations. For 
example, alpha-satellite DNA at centromeres replicates at mid-S-phase in a variety of 
human cell types (O’Keefe et al., 1992). Also, active rDNA replication foci labeled by EdU 
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pulse became activated early in S-phase, while inactive rDNA repeats replicated later 
(Dimitrova 2011). Early replicated rDNA repeats were then repositioned to the nucleolar 
interior where they coincided with RNA polymerase I transcription factor UBF, indicating 
that these replicated regions are transcriptionally active rDNA genes (Dimitrova 2011). 
After completion of a number of cell cycles following tagged-dUTP incorporation, the 
number of labeled chromosome territories eventually decreases by successive distribution to 
daughter nuclei such that individual chromatin territories are labeled and can be compared 
relative to other objects or gene loci. Fluorescently tagged nucleotide (e.g. Cy5-dUTP) is also 
useful for imaging DNA strand condensation into chromosomes and to monitor 
chromosome organization through mitosis (Manders et al., 1999). Chromosome painting 
techniques in fixed cells have supported the model that individual chromosomes occupy 
discrete nuclear regions during interphase (Cremer et al., 1993). A significant advance in 
understanding chromatin dynamics was made with histone H2B-green fluorescent protein 
(GFP), which incorporates into mononucleosomes without disturbing the cell cycle (Kanda 
et al., 1998). H2B-GFP labeled chromatin was originally used to follow the position and 
segregation of double minute chromosomes during mitosis (Kanda et al., 1998). Widespread 
use of H2B-GFP in many subsequent studies has given more global insight into the 
organization and dynamics of chromatin. H2B-GFP observation in living HeLa cells has 
shown that chromosomes maintain nuclear position or “neighborhoods” through 
interphase, but become repositioned to new neighborhoods following mitosis (Walter, 2003). 
In other studies, mitotic chromosomes were demonstrated to have remarkably ordered 
positioning suggesting that chromosome position is transmissible (Gerlich et al., 2003). 
Photobleaching experiments showed clearly that a region of YFP-H2B chromatin located at 
the extreme end of an interphase nucleus would become distributed to many subnuclear 
regions distributed throughout post-mitotic daughter nuclei (Walter et al., 2003). Because 
spindle tension draws sister chromatids of adjacently situated chromosomes at the 
metaphase plate to roughly the same regions of the daughter cell, there is relative symmetry 
of chromosome arrangement in daughter nuclei. However, the pattern of chromosome 
territories in daughters is not similar to the pattern of the mother cell, and overall 
chromosome territory pattern appears to rearrange significantly with each cell cycle (Walter 
et al., 2003).  
Temporal control of replication timing must be reinitiated with each cell cycle, and many 
questions regarding how the timing and organization is controlled remain unanswered 
(reviewed in Lucas & Feng, 2003). It will be particularly interesting to follow the activity of 
specific replication proteins through the cell cycle, or to know what specific nuclear 
structures/complexes might support dynamic assembly of replication foci. Basic research in 
this regard will be crucial for us to understand the mechanisms that underlie observed 
differences in replication of specific gene loci in diseased cells versus normal cells. For 
example, malignant cells demonstrated less synchrony in replication of homologous loci, 
having early and late replicating alleles rather than synchronously replicating alleles found 
in normal cells (Amiel et al., 1998). Also, the spatial organization of DNA replication foci 
within the nucleus during early S-phase, and the association of these replication foci with 
intranuclear lamin A/C was altered in immortalized cells (Kennedy et al., 2000). An 
understanding of how replication of a gene locus is tied to its transcriptional activity may 
also shed light on why replication organization and timing is altered in disease. In order to 
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address such questions, it will be important to analyze cell cycle dependent events in large 
numbers of cells. A very promising new technique for measuring cell cycle dependent 
growth was demonstrated recently, using spatial light interference microscopy (SLIM) 
coupled with a fluorescence marker for S-phase to analyze cell cycle phase within a cell 
population (Mir et al., 2011). The applications for this technique to a range of cell types, as 
well as to microscopy systems that utilize multi-channel fluorescence imaging, open endless 
possibilities for developing variations on this method to image cellular metabolism in the 
context of cell growth even within a complex cellular population.  
5. Conclusion 
The rapid progress recently made toward developing metabolic tracer molecules shows 
great promise for new applications in clinical diagnostics. Further characterization of novel 
imaging probes is needed to understand how they can be used to image and identify 
malignant tissues. Rapidly screening novel tracer molecules for efficacy in identifying 
tumors in cell culture systems, animal models and clinical trials is a crucial ongoing 
challenge aimed toward building a battery of tools for imaging cancer metabolism in 
patients. Feeding into clinical studies is a vast amount of knowledge gained from basic 
research characterizing metabolic pathways in single cells. This information has potential 
for wide use for diagnostic imaging, but awaits further research and development into 
translational medicine that will utilize novel biomarkers and imaging technologies. Finally, 
continued development of super-resolution imaging platforms for both basic research and 
clinical use are certain to have a major impact on our understanding of molecular 
complexes, especially with regard to colocalization of specific protein-protein, protein-RNA 
or protein-DNA complexes within the overall context of cellular architecture.  
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